These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
442 related items for PubMed ID: 17884829
21. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients. Pouch SM, Kubin CJ, Satlin MJ, Tsapepas DS, Lee JR, Dube G, Pereira MR. Transpl Infect Dis; 2015 Dec; 17(6):800-9. PubMed ID: 26341757 [Abstract] [Full Text] [Related]
22. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Kalpoe JS, Sonnenberg E, Factor SH, del Rio Martin J, Schiano T, Patel G, Huprikar S. Liver Transpl; 2012 Apr; 18(4):468-74. PubMed ID: 22467548 [Abstract] [Full Text] [Related]
26. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy. Lautenbach E, Metlay JP, Bilker WB, Edelstein PH, Fishman NO. Clin Infect Dis; 2005 Oct 01; 41(7):923-9. PubMed ID: 16142655 [Abstract] [Full Text] [Related]
29. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors. Amit S, Mishali H, Kotlovsky T, Schwaber MJ, Carmeli Y. Clin Microbiol Infect; 2015 Jan 01; 21(1):30-4. PubMed ID: 25636924 [Abstract] [Full Text] [Related]
30. The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China. Qin X, Wu S, Hao M, Zhu J, Ding B, Yang Y, Xu X, Wang M, Yang F, Hu F. J Infect Dis; 2020 Mar 16; 221(Suppl 2):S206-S214. PubMed ID: 32176790 [Abstract] [Full Text] [Related]
31. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). Maltezou HC, Giakkoupi P, Maragos A, Bolikas M, Raftopoulos V, Papahatzaki H, Vrouhos G, Liakou V, Vatopoulos AC. J Infect; 2009 Mar 16; 58(3):213-9. PubMed ID: 19246099 [Abstract] [Full Text] [Related]
32. In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae. Huang W, Qiao F, Zhang Y, Huang J, Deng Y, Li J, Zong Z. Clin Infect Dis; 2018 Nov 13; 67(suppl_2):S225-S230. PubMed ID: 30423052 [Abstract] [Full Text] [Related]
33. Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit. Vardakas KZ, Matthaiou DK, Falagas ME, Antypa E, Koteli A, Antoniadou E. J Infect; 2015 Jun 13; 70(6):592-9. PubMed ID: 25447713 [Abstract] [Full Text] [Related]
34. Risk factors and mortality in the Carbapenem-resistant Klebsiella pneumoniae infection: case control study. Akgul F, Bozkurt I, Sunbul M, Esen S, Leblebicioglu H. Pathog Glob Health; 2016 Jun 13; 110(7-8):321-325. PubMed ID: 27903130 [Abstract] [Full Text] [Related]
35. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China. Liu C, Liu L, Jin MM, Hu YB, Cai X, Wan L, Zhang HY, Li RY, Wu XJ. Curr Med Sci; 2022 Feb 13; 42(1):68-76. PubMed ID: 34985611 [Abstract] [Full Text] [Related]
38. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates. Kopterides P, Koletsi PK, Michalopoulos A, Falagas ME. Int J Antimicrob Agents; 2007 Nov 13; 30(5):409-14. PubMed ID: 17851052 [Abstract] [Full Text] [Related]
39. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. Psichogiou M, Tassios PT, Avlamis A, Stefanou I, Kosmidis C, Platsouka E, Paniara O, Xanthaki A, Toutouza M, Daikos GL, Tzouvelekis LS. J Antimicrob Chemother; 2008 Jan 13; 61(1):59-63. PubMed ID: 17999975 [Abstract] [Full Text] [Related]